nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Announcement: online access to lung cancer for IASLC members from January 2002
|
|
|
2002 |
35 |
1 |
p. viii- 1 p. |
artikel |
2 |
A phase II study of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer: clinical outcomes and quality of life
|
Jassem, Jacek |
|
2002 |
35 |
1 |
p. 73-79 7 p. |
artikel |
3 |
Calender of events
|
|
|
2002 |
35 |
1 |
p. vii- 1 p. |
artikel |
4 |
Carboplatin—etoposide combination in small cell lung cancer patients older than 70 years: a phase II trial
|
Larive, S. |
|
2002 |
35 |
1 |
p. 1-7 7 p. |
artikel |
5 |
Commentary on “Carboplatin–etoposide association in small cell lung cancer patients older than 70 years: a phase II trial”
|
Murray, Nevin |
|
2002 |
35 |
1 |
p. 9-10 2 p. |
artikel |
6 |
Computed tomography screening for lung cancer in asbestos-exposed workers
|
Tiitola, Mia |
|
2002 |
35 |
1 |
p. 17-22 6 p. |
artikel |
7 |
Contents
|
|
|
2002 |
35 |
1 |
p. v- 1 p. |
artikel |
8 |
Contents continued
|
|
|
2002 |
35 |
1 |
p. vi- 1 p. |
artikel |
9 |
Correlation between endobronchial ultrasonography (EBUS) images and histologic findings in normal and tumor-invaded bronchial wall
|
Baba, Masayuki |
|
2002 |
35 |
1 |
p. 65-71 7 p. |
artikel |
10 |
Cost-minimisation analysis of three regimens of chemotherapy (docetaxel–cisplatin, paclitaxel–cisplatin, paclitaxel–carboplatin) for advanced non-small-cell lung cancer
|
Rubio-Terrés, Carlos |
|
2002 |
35 |
1 |
p. 81-89 9 p. |
artikel |
11 |
Diet and adenocarcinoma of the lung: a case–control study in Uruguay
|
De Stefani, Eduardo |
|
2002 |
35 |
1 |
p. 43-51 9 p. |
artikel |
12 |
Expression of MAGE-12 in lung cancer
|
Wu, Yuzhang |
|
2002 |
35 |
1 |
p. 95- 1 p. |
artikel |
13 |
Instructions to authors
|
|
|
2002 |
35 |
1 |
p. 101-102 2 p. |
artikel |
14 |
Lung cancer in patients with psychiatric disorders
|
Satoh, Hiroaki |
|
2002 |
35 |
1 |
p. 97- 1 p. |
artikel |
15 |
Mutational analysis of the β-tubulin gene in lung cancer
|
Tsurutani, Junji |
|
2002 |
35 |
1 |
p. 11-16 6 p. |
artikel |
16 |
Patient's and doctors’ delays in the diagnosis of chest tumors
|
Koyi, Hirsh |
|
2002 |
35 |
1 |
p. 53-57 5 p. |
artikel |
17 |
Pleural small cell carcinoma in pre-existent asbestos related pleural disease
|
van der Heijden, H.F.M. |
|
2002 |
35 |
1 |
p. 91-94 4 p. |
artikel |
18 |
Prognostic relevance of proliferating cell nuclear antigen and p53 expression in non-small cell lung cancer
|
Dworakowska, D. |
|
2002 |
35 |
1 |
p. 35-41 7 p. |
artikel |
19 |
Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer
|
Villegas, Francisco R. |
|
2002 |
35 |
1 |
p. 23-28 6 p. |
artikel |
20 |
Serum endostatin correlates with progression and prognosis of non-small cell lung cancer
|
Suzuki, Makoto |
|
2002 |
35 |
1 |
p. 29-34 6 p. |
artikel |
21 |
Single-agent pegylated liposomal doxorubicin (Caelix®) in chemotherapy pretreated non-small cell lung cancer patients: a pilot trial
|
Numico, Gianmauro |
|
2002 |
35 |
1 |
p. 59-64 6 p. |
artikel |
22 |
Summary of the First IASLC China Studying Program of Lung Cancer
|
Hou-wen, L. |
|
2002 |
35 |
1 |
p. 99-100 2 p. |
artikel |